IP Library Granted Patent US 8,865,138
Granted Patent B2
US 8,865,138 · App. 13/532,289 · Granted Oct 21, 2014

Melanin modification compositions and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,865,138
App. No.
13/532,289
Granted
Oct 21, 2014
Kind
B2
Abstract

A method for the modification of melanin distribution, and the composition thereof to modify melanin distribution are disclosed. A method for the reduction of melanin distribution, and the composition thereof to reduce melanin distribution are disclosed. A representative composition comprises 4-ethoxybenzaldehyde and one or more additional active agents as well as a pharmaceutically acceptable carrier or excipient. Carriers and excipients may be formulated for topical administration. Compositions may also be formulated for transdermal administration. The compositions may be used for the prevention and treatment of pigmentation disorders, by way of non-limited example, post-inflammatory hyperpigmentation and others. The compositions may be used for lightening skin.

Claims (9)

1. A composition comprising from about 0.01% to about 2% of 4-ethoxybenzaldehyde, from about 0.01% to about 5.0% each of retinol, niacinamide, tetrahexyldecyl ascorbate, glycyrrhiza qlabra (licorice) root extract, hexyl resorcinol, and ethyl linoleate, and a pharmaceutically or cosmetically acceptable carrier.

2. The composition of claim 1 , wherein the amount of the 4-ethoxybenzaldehyde in the composition is about 0.5%.

3. The composition of claim 1 , wherein when topically administered the composition lightens skin.

4. The composition of claim 1 , wherein when topically administered the composition treats hyperpigmentation or a hypermelanosis disorder.

5. The composition of claim 1 , wherein the composition reduces melanin distribution by about 10% to about 40% when applied to skin.

6. The composition of claim 1 , further comprising one or more additional active agents.

7. The composition of claim 6 , wherein the additional active agent is an antioxidant, a sunscreen, a sunprotectant, a sunblock, a skin-lightening agent, an anti-inflammatory agent, an anti-acne agent or mixtures thereof.

8. The composition of claim 1 , wherein the pharmaceutically or cosmetically acceptable carrier is a topical carrier.

9. The composition of claim 8 , wherein the topical carrier is a water-in-oil emulsion, cream, liquid, gel, oil, paste, ointment, suspension, foam, lotion, oil-in-water emulsion, water-in-oil-in-water emulsion, water-in-silicone emulsion, spray or serum carrier.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2013
From: SKINMEDICA, INC.
To: ALLERGAN, INC.
Reel/Frame 029752/0926 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2012
From: MEHTA, RAHUL C.; MAKINO, ELIZABETH TSIN HO; SONTI, SUJATHA D.; GARRUTO, JOHN A.
To: SKINMEDICA, INC.
Reel/Frame 028516/0154 →